CMBA
PRTA icon

C.M. Bidwell & Associates’s Prothena Corp PRTA Stock Holding History

C.M. Bidwell & Associates’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-50
Closed -$3.01K – 555
2022
Q4 		$3.01K Hold
50
– – ﹤0.01% 404
2022
Q3 		$3K Hold
50
– – ﹤0.01% 407
2022
Q2 		$1K Hold
50
– – ﹤0.01% 467
2022
Q1 		$2K Hold
50
– – ﹤0.01% 481
2021
Q4 		$2K Buy
+50
New +$2.77K ﹤0.01% 521

Other funds holding PRTA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

C.M. Bidwell & Associates's PRTA Position: Q1 2023 in Review

C.M. Bidwell & Associates sold out of Prothena Corp (PRTA) in Q1 2023, closing a stake of 50 shares — an estimated $3.01K sold.

C.M. Bidwell & Associates first reported a position in PRTA in Q4 2021 and held it in 5 quarters. The position peaked at $3.01K in Q4 2022. 191 funds tracked by Wall St. Rank hold PRTA as of Q1 2023.

  • C.M. Bidwell & Associates reported no remaining Prothena Corp position as of Q1 2023 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 50 Prothena Corp shares in Q1 2023, an estimated $3.01K.
  • C.M. Bidwell & Associates first reported a position in Prothena Corp in Q4 2021 and held it in 5 quarters.
  • C.M. Bidwell & Associates's Prothena Corp position peaked at $3.01K in Q4 2022.
  • 191 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2023.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2023, filed 12 May 2023.